Using a continuous intravenous infusion of D-(-)-3-hydroxy [4,4,4-2H3]butyrate tracer, we measured total ketone body transport in 12 infants: six newborns, four 1-6-mo-olds, one diabetic, and one hyperinsulinemic infant. Ketone body inflow-outflow transport (flux) averaged 17.3 +/-1.4 mumol kg-1 min-1 in the neonates, a value not different from that of 20.6 +/-0.9 mumol kg-1 min-1 measured in the older infants. This rate was accelerated to 32.2 mumol kg-1 min-1 in the diabetic and slowed to 5.0 mumol kg-1 min-1 in the hyperinsulinemic child. As in the adult, ketone turnover was directly proportional to free fatty acid and ketone body concentrations, while ketone clearance declined as the circulatory content of ketone bodies increased. Compared with the adult, however, ketone body turnover rates of 12.8-21.9 mumol kg-1 min-1 in newborns fasted for less than 8 h, and rates of 17.9-26.0 mumol kg-1 min-1 in older infants fasted for less than 10 h, were in a range found in adults only after several days of total fasting. If the bulk of transported ketone body fuels are oxidized in the infant as they are in the adult, ketone bodies could account for as much as 25% of the neonate's basal energy requirements in the first several days of life. These studies demonstrate active ketogenesis and quantitatively important ketone body fuel transport in the human […] Abstract Using a continuous intravenous infusion of D-(-)-3-hy-droxyl4,4,4_2H31butyrate tracer, we measured total ketone body transport in 12 infants: six newborns, four 1-6-mo-olds, one diabetic, and one hyperinsulinemic infant. Ketone body inflow-outflow transport (flux) averaged 17.3±1.A Mmol kg-' min' in the neonates, a value not different from that of 20.6±0.9 !mol kg-' min' measured in the older infants. This rate was accelerated to 32.2 jAmol kg-' min' in the diabetic and slowed to 5.0 gsmol kg-' min-' in the hyperinsulinemic child. As in the adult, ketone turnover was directly proportional to free fatty acid and ketone body concentrations, while ketone clearance declined as the circulatory content of ketone bodies increased.
Introduction
In addition to producing glucose at the rate of about 9 g kg-' d-' (1) , the human newborn develops accelerated lipid mobilization from its large fat stores (2) in order to meet energy requirements. The release of fatty acids from adipose tissue occurs at a rate of -4-5 g kg-' d-' during the first days of life (3), and serves a dual role in fuel homeostasis: it serves in substrate delivery both for direct energy supply and for ketogenesis. Because of the precarious balance between neonatal glucose production and the almost equal glucose utilization requirements of the 400-g newborn brain (1) , there is an absolute need for alternative fuels capable of sparing (or replacing) glucose for cerebral nutrition. Free fatty acids, while providing several tissues with readily oxidizable substrates, cannot cross the blood-brain barrier Receivedfor publication 8 April 198S. to be utilized by the brain. However, their water-soluble derivatives, acetoacetate (AcAc)' and 3-hydroxybutyrate (3-OHB), besides being used as fuel by tissues (4) , have the unique capacity of replacing glucose for the energy needs of the central nervous system in humans (5) . Since this capacity is already functional in the immature human brain (6) (7) (8) (9) , ketone bodies might play an important role in the caloric homeostasis of newly born infants. Furthermore, AcAc and 3-OHB are important precursors for the synthesis of structural lipids in the developing human brain (10) . Whether fasted for the first 24 h of life (11, 12) or fed under current nursery practices (3, 13) , newborn infants have a degree of ketosis that is achieved by the adult only after 1-2 d of total starvation ( 14) . Nevertheless, there are no quantitative measurements of ketone body transport in the human newborn. Recently we developed a gas chromatography-mass spectrometry (GCMS) approach using nonradioactive, deuterium-labeled 3-OHB tracer, which has allowed us to make these measurements in the human neonates in an ethically acceptable fashion. In addition, ketone body turnover was also measured in older infants (1-6 mo of age) to evaluate the quantitative importance of these substrates during short-term fasting.
Methods
Patients. Glucose and ketone body turnover rates were measured simultaneously in six newborns (group A) and four older infants (group B). In addition, one infant with insulin-dependent diabetes mellitus and another with hyperinsulinism were studied. The clinical characteristics of the infants are presented in Table I . Infants in group A were born at term and appropriate weight for gestational age, estimated from the date of the mother's last menstrual period and by physical examination (15) . All infants were born after an uncomplicated pregnancy, but infant 5 had a low initial Apgar score responding to routine resuscitation. Four mothers had premature rupture of membranes and one mother had a temperature of 38.50C during labor. Thus, five of the newborns studied were receiving intravenous antibiotic therapy, but in none was infection confirmed by culture. At the time of the study, all infants were asymptomatic, resting comfortably in an isolette or a crib, and covered with a blanket to avoid hypothermia during the study. Medical care of each newborn was under control of the child's physician who designated the infant's feeding schedule according to his routine nursery practice, so that none of the infants was specifically fasted for the purpose of the tracer experiment. Subjects I and 2 had received no oral feedings before the study. These two infants, and the four others treated with intravenous antibiotics, received intravenous dextrose at a "keep-open" rate of <I mg dextrose kg-' min-'. In each instance, the intravenous solution was switched to 0.45% saline a minimum of 3 h before starting the tracer experiment. Infants of Group B were referred patients: two of them because of suspected but undocumented hypoglycemia (and later proved to be normal infants on a metabolic and endocrine basis), and the two 1. Abbreviations used in this paper: AcAc, acetoacetate; [2H3AAcAc, [4,4,4- 2H3Jacetoacetate; GCMS, gas chromatography-mass spectrometry; 3-OHB, 3-hydroxybutyrate; [2H3]OHB, D-(-)-3-hydroxy [4,4,4- 2H3]butyrate. others because of viral diarrhea with weight loss < 10% of body weight. Thus, subjects 7 and 8 were fasted as part of routine evaluation for hypoglycemia, while subjects 9 and 10 had resumed normal feeding for 2-3 d before the study. Infant 11 was referred to our clinic for hypoglycemia, which was proven to be due to insulin excess by a diagnostic fasting test that disclosed a rapid decrease of plasma glucose associated with increased plasma insulin concentration (63 iU/ml). The tracer study was performed during this fasting test.
Infant 12 had insulin-dependent diabetes mellitus previously treated using continuous subcutaneous insulin pump therapy (16). As part of a separate research protocol evaluating the potential risks of this therapy in very young children (16) , and the metabolic consequences following abrupt interruption ofthe insulin infusion, this child's glucose and ketone kinetics were studied under close in-hospital medical control. The tracer study was thus started 2 h after pump therapy was discontinued.
Materials. D(-)-3-hydroxy[4,4,4-2H3]butyrate (92% atom % 2H3), and D-[6,6-2H2]glucose (97 atom % 2H2) were purchased from Merck, Sharp and Dohme Canada, Ltd., Montreal, Quebec, Canada. Chemical and isotopic purity were confirmed by conventional enzymatic, gas chromatographic, and mass spectrometric analyses. Each preparation was pyrogen-free by standard rabbit body temperature measurements after intravenous administration according to federal guidelines in a licensed commercial laboratory. D-(-)-3-hydroxy[4,4,4-2H3]butyrate and [6,6-2H2Jglucose were dissolved in 0.5 N saline and prepared for human use as described (1) .
Procedural methods. Infants were studied after obtaining parental consent according to protocols approved by the Saint-Vincent-de-Paul and Institute National de la Sante et de la Recherche Medicale (INSERM) Committees on Ethics in Human Experimentation. In all ofthe newborns, and in infants 9 and 10, the peripheral intravenous "scalp vein" needle already in place for antibiotic or fluid administration was used for tracer infusion. In the remaining infants (numbers 7,8, 11, and 12), a 25-gauge "scalp vein" needle was inserted into a peripheral vein at least 2 h before the onset of the tracer infusion.
At time zero of the study, we collected base-line samples (see below) and began continuous infusion of labeled tracers using a calibrated syringe pump at the rate of0.266±0.025 (SEM) Mmol kg-' min-' D-(-)-3-hydroxy[4,4,4-2H3]butyrate ([2H3]OHB) and 0.446±0.017 gmol kg-' min-' D-[6,6-2H2jglucose. These rates of infusion were maintained for 120 min in all studied infants. Before the start of the study, and every 10 min from 90 to 120 min, 500 gI "heel stick" arterialized capillary blood samples were collected into iced heparinized tubes. Plasma proteins and blood cells were precipitated from separate I00-ul and 300-ul blood aliquots in preweighed iced centrifuge tubes containing 300 and 700 M1 of cold 10% perchloric acid, respectively, for subsequent measurement of substrate concentrations and ketone body isotopic enrichment (see below). Plasma from the remaining 100 ,ul of blood was immediately separated by high speed centrifugation and kept frozen at -20°C for subsequent measurement of glucose isotopic enrichment (see below). An additional 200-IMI blood sample was obtained at the end of the study and the plasma was mixed with 800,l of water and 3 ml of Dole's mixture for subsequent measurement of free fatty acid (FFA) concentration. Urine was collected at the end ofthe study and for the following 2 h and kept frozen at -20°C.
Analytical methods. Blood glucose, acetoacetate, and D(-)-3-hydroxybutyrate were measured spectrophotometrically by specific enzymatic micromethods (17) within 12 h after collecting blood samples.
Isotopic enrichments in circulating [2H3]OHB and in [4,4,4- 2H3Jacetoacetate ([2H3AAcAc) were measured by selected ion monitoring GCMS as recently described (1 7a). Briefly, after addition of blood, the perchloric acid supernatant was separated by high speed centrifugation and the pH was adjusted to 6.5-7.0 with 10% KOH. Potassium perchlorate salts were precipitated and the remaining supernatant was acidified with 100 Ml of 1 N HCI. The regenerated ketoacids were immediately extracted into ethylacetate and converted to their respective trimethylsilyl ester derivatives by treatment with 10% pyridine in N,O-bis-trimethylsilyltrifluoroacetamide. The resultant 3-OHB and AcAc trimethylsilyl esters were resolved by gas chromatography as described (17a). butyrate are partitioned to the same degree in acetoacetate and measure identical total ketone body turnover rates (1 7a).
To measure [6,6-2H2Jglucose enrichment, we added 50 ul of plasma to 250 ,l of 0.3 N barium hydroxide and precipitated the proteins by adding 250 Ml of0.3 N zinc sulfate. After centrifugation, the supernatant Neonatal Ketone Transport was subjected to sequential anion and cation exchange chromatography (1) and the neutral eluate was used to measure plasma [6,6-2H2]glucose enrichment by selected ion monitoring GCMS as described (1, 18) . Plasma total FFA content was calculated from the summed individual fatty acid methyl ester gas chromatography peak areas referenced to heptadecanoic acid as internal standard (19) .
Calculations. Blood total ketone body (AcAc + 3-OHB) inflow transport (or rate of appearance, R.), rate of outflow (or disappearance, Rd), and clearance rate (RJ) were calculated from samples taken between 90 and 120 min of study. In all studied infants, both blood AcAc and 3-OHB content and the [2H3] enrichment in each ketone remained reasonably constant (SD/mean < 0.15) and were considered at or near steady state. In this situation, treatment of kinetic data can be carried out either by the "single pool" approach (20) (21) (22) (23) , with blood AcAc and 3-OHB pools being lumped as one, or by the "two accessible pools" approach (24, 25) considering blood AcAc and 3-OHB pools separately.
There was rapid formation of [2H3]AcAc from [2H3]OHB, with both ketones retaining the deuterium atoms in position 4. Since, at steady state, [2H3]AcAc enrichment averaged 67.1±3.5% (SE) that of the [2H3]OHB tracer, we considered that 3-OHB and AcAc were interconverted rapidly enough to minimize the error of considering them in the same pool. Barton (26) has shown that under the conditions ofthe current study (i.e., 3-OHB/AcAc concentration ratio of -2.7 and [2H3]OHB/ [2H3JAcAc enrichment ratio -1.55), relative error introduced by the use of the conventional "single pool" analysis for estimation ofturnover rates and metabolic clearance of ketone bodies was no more than 10-15% (26) . Moreover, the constant infusion of [2H3JOHB tracer allows stochastic calculation of ketone body turnover rates, thereby avoiding a number of structural and computational assumptions that are not necessarily valid (27 Because each subject also achieved approximately constant values (SD/mean < 5%) for plasma glucose and [6,6-2H2lglucose enrichment, similar steady state equations were employed for the calculation ofglucose turnover rate, as described (1) . Total FFA inflow and outflow transport rates were estimated from plasma FFA concentrations and the established linear relationship between plasma FFA content and transport in newborn infants (3) .
Results
Substrate levels. Plasma substrates in the studied infants are presented in Table II . In group A, none of the newborns was hypoglycemic, although number 5 had a plasma glucose level at the lower normal limit at the time of the study. Neonatal blood AcAc and 3-OHB concentrations averaged 296±112 ,uM (SEM) and 486±67 MM, respectively, with a 3-OHB/AcAc concentration ratio of 3.0±1.0. Total circulating ketone bodies were 781 ± 172 AM. These values are in the range previously reported for newborns in their first days of life having a similar feeding schedule (3, 13) . Plasma FFA level averaged 810±206 MM, a value in newborns that is similar to that previously reported by us for similar infants (3).
Infants of group B had blood total ketone body and FFA concentrations averaging 1,250±241 MM and 956±110 MM, respectively, within or near normal physiological values for similarly fasted infants. The 3-OHB/AcAc concentration ratio was 2.70±0.03, a normal value. Infant 11 had a low plasma glucose (43 mg/dl) after only 3 richment ratio (0.67±0.03) indicated extensive interconversion between blood 3-OHB and AcAc, resulting in an average [2H3J enrichment of 1.34±0.1 atom percent excess for blood total ketones in group A and B infants. During the last 30 min of study, the inflow-outflow transport rates of blood total ketone bodies were nearly identical in each subject population and averaged 17.3±1.4 gmol kg-' min' in group A infants, and 20.6±0.93 ,umol kg-' min-in group B infants, values not reached in adults until they are fasted for 3-23 d (14, 20, 23, (27) (28) (29) (30) . As expected, ketone body production was decreased in the hyperinsulinemic child (infant number 1 1), and increased in the diabetic child (infant number 12) after insulin withdrawal. There was a direct linear relationship (r = 0.8, P < 0.002) between blood ketone level and rate of inflow-outflow transport (Fig. 1 ) as reported in adults over a similar range ofblood ketone concentration ( 14, 21, 23) . Blood ketone body clearance rate ranged from 12 to 51 ml kg-' min-' (average, 28.6±6.6 ml kg-' min' in group A, and 17.8±2.8 ml kg-' min' in group B) and correlated nega-tively (r = 0.87, P < 0.001) with blood ketone concentration ( Fig. 2) , as previously reported in fasted adults (21, 23) .
From the infants' FFA values and the regression equation previously defined in a similar group of newborns (3), the plasma FFA inflow-outflow rate could be estimated for each infant (Table IV). FFA turnover averaged 14±2 Amol kg-' min' in the newborns, and 15±1 gmol kg-' min' in group B infants in 3) . There was no significant relationship between glucose and ketone body respective transport rates. As again expected, infant 11 had decreased glucose production, as shown in other hyperinsulinemic children (28) , and infant 12 with diabetes mellitus, had a dramatic increase of glucose turnover. 3 ,000 Figure 2 . The relationship between ketone body concentrations and their clearance rates from blood in the infants studied. The symbols are the same as for Fig. 1 .
good agreement with the value of 11.5±1.7 Amol kg-' minpreviously measured in neonates (3) . Plasma FFA (and therefore FFA outflow rate) were correlated (r = 0.6, P < 0.002) with ketone body production ( Fig. 3) as anticipated from the precursor-product relationship between FFA and ketone bodies. Because the synthesis of 1 mol ofAcAc or 3-OHB requires -0.25 mol of plasma FFA, and assuming that all ketones are derived from FFA oxidation, the amount ofFFA utilized for ketogenesis was estimated from ketone body production rate. Thus, 4.2±0.54
,umol kg' min-of FFA were converted to ketone bodies in group A, and 5.2±0.5 Mmol kg-' min-' in group B infants.
Discussion
Although ketone bodies are generally regarded as important metabolic fuels in the newborn infant (31, 32) , we are not aware of direct measurement of their transport rates in this age group. This study shows that ketone body production and utilization are very active processes that occur at accelerated rates in term newborns, even when these neonates are fed every 4 h according to current nursery practices. The observed neonatal ketone body transport rates of 12.8-21.9 Mmol kg-' min', and those in older infants fasted for -8 h (17.9-26.0 umol kg-' min-'), are achieved by the adults only after several days of starvation ( 13, 21, 23, (28) (29) (30) 33) . Because the newborn is currently fed on a basis of approximately every 4 h, the total daily ketone body transport can, therefore, be estimated to be on the order of 2-3 g kg-' d-'. In fasted adults, about 85% of ketone body production is oxidized, mostly in brain, muscle, and kidney (14) . PLASMA FFA(pM) Figure 3 . The relationship between plasma free fatty acid concentration and the plasma inflow rate (R.) of ketones in the studied infants.
The symbols are the same as those for Fig. 1 . The solid regression line calculated from the infant data is defined by the equation Y = 0.0056X + 13.7. The dotted line is calculated from averaged similar data in adults (references 14, 21, 23, 28) and has the function Y = 0.014X + 3.8.
If one assumes the same fractional oxidation rate for the newborn, the neonate would oxidize -2 g of ketone bodies per kilogram body weight daily. This oxidation would yield the equivalent of -10 kcal kg-' d-', one-fourth of the minimal, basal energy requirements on the first days of life for an infant in a thermoneutral environment (34) . Most importantly, at a time when glucose production is just sufficient to serve the demand of the newborn brain (1), ketone bodies can thus serve as alternate substrates for the oxidative requirement of the central nervous system. Recent in vivo studies of cerebral metabolism in infants confirm that the immature brain can utilize ketone bodies at rates of 3-8 Mmol/l00 g brain weight per minute (6, 7, 9) , Thus, a 3.5-kg term newborn with a 420-g brain could extract 13-34 smol of ketone bodies per minute (4-10 Mmol/ kg body weight per minute) to serve cerebral ketone body oxidation alone. The newborn's central nervous system then might consume approximately one-fourth to one-half of daily hepatic ketone body output in neonates and young infants. As in the adult (21, 23) , ketone levels in our infants were directly correlated with outflow transport (Fig. 1 ) and inversely correlated with metabolic clearance rate (Fig. 2 ). However, both outflow transport and clearance rates were about two times greater in newborns and young infants than in adults having similar ketone body levels (14, 21, 23) . This increased capacity for taking up ketone bodies from the blood stream in the neonate is consistent with its large brain size in relation to total body weight, and the fourfold increase in neonatal cerebral ketone body uptake compared with the adult (6, 9) . The close agreement between the regression equation for ketone body production and FFA levels in our patients and the regression calculated from data presented in adult studies (14, 21, 23, 28) (Fig. 3) is supported by the similar fraction (=301%) of the FFA flux, which is converted into ketones (35) . These similar relationships, taken together with the ability of the neonate to produce large amounts of ketones, suggest that ketogenesis is already mature in humans on the first day of life, and that the intrahepatic and extrahepatic regulatory systems controlling the conversion of FFA into KB are well established by this early postnatal age.
